PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11686491-3	2001	Under non-brain injury conditions, topical ET-1 (10(-10) M, the concentration present in CSF following FPI) increased SOD-inhibitable NBT reduction from 1 +/- 1 to 17 +/- 3 pmol/mm2.	Nitroblue Tetrazolium	134-137	endothelin-1	Sus scrofa	43-47	
8996511-10	1997	Topical ET-1 (10(-10) mol/L) increased SOD-inhibitable NBT reduction from 1 +/- 1 to 16 +/- 3 pmol/mm2, similar to previously reported NBT reduction after FPI (14 +/- 2 pmol/mm2).	Nitroblue Tetrazolium	55-58	endothelin-1	Sus scrofa	8-12	
8996511-11	1997	BQ123 (10(-6) mol/L), an ET-1 antagonist, blunted the NBT reduction observed after FPI (4 +/- 1 pmol/mm2).	Nitroblue Tetrazolium	54-57	endothelin-1	Sus scrofa	25-29